Bronchodilator Responses to Salbutamol Using Diskhaler Versus Metered-Dose Inhaler

References

• Kemp JP. Approaches to asthma management. Realities and recommendations. Arch Intern Med 1993; 153: 805–812
   PubMedGoogle Scholar
• British Thoracic Society. Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign: Guidelines for management of asthma in adults: 1. Chronic persistent asthma. Br Med J 1990; 301: 651–653
   PubMed Web of Science ®Google Scholar
• National Asthma Education Program. Sheffer AL (Chair, Expert Panel on Management of Asthma) Guidelines for the Diagnosis and Management of Asthma. Office of Prevention, Education, and Control; National Heart Lung, and Blood Institute, National Institutes of Health. US Dept of Health and Human Services, Bethesda, MD 1991
   Google Scholar
• British Thoracic Society. Participants-Barnes PJ, Barnett AH, Brewis RAL, et al: Guidelines for the management of asthma: a summary. Br Med J 1993; 306: 776–777
   Google Scholar
• British Thoracic Society The Research Unit of the Royal College of Physicians of London, the King's Fund Centre, and the National Asthma Campaign, the British Paediatric Association and the British Paediatric Respiratory Group, British Association for Accident and Emergency, the Royal College of General Practitioners and the General Practitioners in Asthma Group. Guidelines on the management of asthma. Thorax 1993; 48: Sl–S24, (Suppl)
   Google Scholar
• Chapman KR, Kesten Szalai JP. Regular vs as-needed inhaled salbutamol in asthma control. Lancet 1994; 343: 1379–1382
   PubMed Web of Science ®Google Scholar
• Saunders KB. Misuse of inhaled bronchodilator agents. Br Med J 1965; 1: 1037–1038
   PubMed Web of Science ®Google Scholar
• Orehek J, Gayrard P, Grimaud C. Patient error in use of bronchodilator metered aerosols. Br Med J 1976; 1: 76
   Web of Science ®Google Scholar
• Paterson IC, Crompton GK. Use of pressurized aerosols by asthmatic patients. Br Med J 1976; 1: 76–77
   PubMed Web of Science ®Google Scholar
• Newman SP, Pavia D, Clarke SW. How should a pressurized β-adrenergic bronchodilator be inhaled?. Eur J Respir Dis 1981; 62: 3–20
   PubMedGoogle Scholar
• Crompton GK. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis 1982; 63: 101–104, Suppl 119
   Google Scholar
• Newman SP. Metered dose pressurized aerosols and the ozone layer. Eur Respir J 1990; 3: 495–497
   PubMed Web of Science ®Google Scholar
• Newman S. Aerosol inhalers. Br Med J 1990; 300: 1286–1287
   PubMed Web of Science ®Google Scholar
• Pover GM, Langdon CG, Jones SR, Fidler C. Evaluation of a breath operated powder inhaler. J Int Med Res 1988; 16: 201–203
   PubMed Web of Science ®Google Scholar
• Delivery systems for inhaled drugs in asthma. Drug Ther Bull 1989; 27(17)66–68
   Google Scholar
• Brown PH, Lenney J, Armstrong S, Ning ACWS, Crompton GK. Breath-actuated inhalers in chronic asthma: comparison of diskhaler and turbohaler for delivery of beta-agonists. Eur Respir J 1992; 5: 1143–1145
   PubMed Web of Science ®Google Scholar
• Lundback B, Rawlinson DW, Palmer JBD. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. Thorax 1993; 48: 148–153
   PubMed Web of Science ®Google Scholar
• Duncan D, Paterson IC, Harris D, Crompton GK. Comparison of the bronchodilator effects of salbutamol inhaled as a dry powder and by conventional pressurized aerosol. Br J Clin Pharmacol 1977; 4: 669–671
   Web of Science ®Google Scholar
• Svedmyr N, Lofdahl C, Svedmyr K. The effect of powder aerosol compared to pressurized aerosol. Eur J Respir Dis 1982; 63: 81–88, Suppl 119
   PubMedGoogle Scholar
• Bronsky E, Bucholtz GA, Busse WW, Chervinsky P, Condemi J, Ghafouri MA. Comparison of inhaled albuterol powder and aerosol in asthma. J Allergy Clin Immunol 1987; 79: 741–747
   PubMed Web of Science ®Google Scholar
• Zainudin BMZ, Biddiscombe M, Tolfree SEJ, Short M, Spiro SG. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurized metered dose inhaler, as dry powder, and as a nebulised solution. Thorax 1990; 45: 469–473
   PubMed Web of Science ®Google Scholar
• Kumana CR, So SY, Lauder IJ, Ip MSM, Lam WK, Kou M. An audit of anti-asthmatic drug utilization, technique and understanding. J Asthma 1993; 30: 263–269
   PubMed Web of Science ®Google Scholar
• Buyse M, Firket P, Nedwick M, Starr M. Data Analysis for Clinical Medicine, TC Chalmers. International University Press. 1988
   Google Scholar
• Minitab. Data Analysis Software Release 7.2. Minitab Inc., State College, PA 1989
   Google Scholar
• Zhong NS. Peak expiratory flow (PEF) in normal subjects and patients with bronchial asthma. Chung-Hua Chieh Ho Ho Hu Hs I Hsi Chi Ping Tsa Chia 1985; 8: 138–141
   Google Scholar
• Gregg I, Nunn AJ. Peak expiratory flow in normal subjects. Br Med J 1973; 3: 282–284
   PubMed Web of Science ®Google Scholar
• Wright BM, McKerrow CB. Maximum forced expiratory flow rate as a measure of ventilatory capacity (with a description of a new portable instrument for measuring it). Br Med J 1959; 2: 1041–1047
   PubMed Web of Science ®Google Scholar
• Wright BM. A miniature Wright peak-flow meter. Br Med J 1978; 2: 1627–1628
   PubMed Web of Science ®Google Scholar
• Williams MH, Jr. Evaluation of asthma. Editorial. Chest 1979; 76-3-4
   Google Scholar
• Tesculescu DB, Hannhart B, Malvestio P, Bahlaoui A, Sadoul P. Evaluation of the performance of 2 mini-flow meters. Rev Mai Respir 1987; 4: 121–125
   Google Scholar
• Brand PLP, Waalkens HJ, Duiverman EJ, van Essen-Zandvliet EEM. The Dutch CNSLC Study Group Inaccuracy of portable peak flow meters: correction is not needed. Acta Paediatr 1997; 86: 888–889
   Google Scholar
• Williams MH Kane C, Shim CS. Treatment of asthma with triamcinolone delivered by aerosol. Am Rev Respir Dis 1974; 109: 538–543
   Google Scholar
• Williams MH Kane C. Dose response of patients with asthma to inhaled isoproterenol. Am Rev Respir Dis 1975; 3: 321–324
   Google Scholar
• Cheong B, Reynolds SR, Rajan G, Ward MJ. Intravenous β-agonist in severe acute asthma. Br Med J 1988; 297: 448–450
   Google Scholar
• Kumana CR, Marlin GE. Selectivity of beta adrenoceptor agonists and antagonists. Recent Advances in Clinical Pharmacology, P Turner, DG Shang. Churchill Livingstone, Edinburgh London New York 1978; 31–54
   Google Scholar
• Nowak RM, Pensler MI, Sarkar DD, Anderson JA, Kvale PA, Ortiz AE, Tomlanovich MC. Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma. Ann Emerg Med 1982; 11: 64–69
   PubMed Web of Science ®Google Scholar
• Henry RL, Mellis CM, South RT, Simpson SJ. Comparison of peak expiratory flow rate and forced expiratory volume in one second in histamine challenge studies in children. Br J Dis Chest 1982; 76: 167–170
   Google Scholar
• Vaughan TR, Weber RW, Tipton WR, Nelson HS. Comparison of PEFR and FEV1 in patients with varying degrees of airway obstruction. Effect of modest altitude. Chest 1989; 95: 558–562
   PubMed Web of Science ®Google Scholar
• Wun YT. Comparison of peak expiratory flow rates read by two portable instruments. J Hong Kong Med Assoc 1994; 46: 61–65
   Google Scholar
• Emerman CL, Cydulka RK. Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease. Ann Emerg Med 1996; 27: 159–163
   PubMed Web of Science ®Google Scholar
• Gautrin D, D'Aquino LC, Gagnon G, Malo JL, Cartier A. Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic. Chest 1994; 306: 1419–1426
   Google Scholar
• Hume KM, Gandevia B. Forced expiratory volume before and after isoprenaline. Thorax 1957; 12: 276–278
   PubMedGoogle Scholar
• Pain MCF, Read J. Patterns of response to bronchodilator in young patients with asthma. Aust Ann Med 1963; 12: 216–220
   Google Scholar
• Melchor R, Biddiscombe MF, Mak VHK, Short MD, Spiro SG. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax 1993; 48: 506–511
   PubMed Web of Science ®Google Scholar
• Newman SP, Weisz AWB, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991; 46: 712–716
   PubMed Web of Science ®Google Scholar
• Ressor Nimmo CJ, Chen DNM, Martinusen SM, Ustad TI, Ostrow DN. Assessment of patient acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-actuated devices. Ann Pharma-cother 1993; 27: 922–927
   Google Scholar
• Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Dwong T, Ball M. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1989; 1: 917–922
   PubMed Web of Science ®Google Scholar
• Sears MR, Taylor DR, Print CG, Lake DC, Li QQ, Flannery EM. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391–1396
   PubMed Web of Science ®Google Scholar
• Beasley R, Nishima S, Pearce N, Crane J. β-agonist therapy and asthma mortality in Japan. Lancet 1998; 351: 1406–1407
   PubMed Web of Science ®Google Scholar